KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.91 $2.61 Friday, 26th Apr 2024 CHRS stock ended at $2.04. This is 5.70% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.74% from a day low at $1.93 to a day high of $2.06.
90 days $1.91 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
Dec 01, 2023 $2.13 $2.30 $2.02 $2.30 3 037 435
Nov 30, 2023 $2.30 $2.49 $2.12 $2.13 4 076 433
Nov 29, 2023 $2.15 $2.34 $2.13 $2.18 3 724 946
Nov 28, 2023 $1.91 $2.16 $1.84 $2.11 3 827 448
Nov 27, 2023 $2.06 $2.06 $1.89 $1.94 2 542 377
Nov 24, 2023 $2.04 $2.13 $2.01 $2.06 1 060 363
Nov 22, 2023 $2.01 $2.08 $1.97 $2.02 2 455 915
Nov 21, 2023 $2.06 $2.08 $1.95 $1.99 3 115 407
Nov 20, 2023 $2.10 $2.30 $2.05 $2.07 4 268 587
Nov 17, 2023 $1.86 $2.15 $1.81 $2.13 8 337 392
Nov 16, 2023 $1.79 $1.80 $1.62 $1.71 3 822 925
Nov 15, 2023 $1.85 $1.97 $1.77 $1.80 6 231 689
Nov 14, 2023 $1.77 $1.86 $1.75 $1.82 6 848 639
Nov 13, 2023 $1.60 $1.73 $1.52 $1.72 7 571 722
Nov 10, 2023 $1.63 $1.63 $1.44 $1.59 7 278 435
Nov 09, 2023 $2.04 $2.09 $1.56 $1.60 15 394 631
Nov 08, 2023 $2.48 $2.52 $2.02 $2.03 10 665 685
Nov 07, 2023 $2.74 $2.83 $2.44 $2.47 12 553 432
Nov 06, 2023 $3.70 $3.73 $3.49 $3.54 4 224 593
Nov 03, 2023 $3.37 $3.73 $3.37 $3.61 4 124 346
Nov 02, 2023 $3.33 $3.45 $3.27 $3.32 2 379 442
Nov 01, 2023 $3.30 $3.47 $3.15 $3.20 3 511 190
Oct 31, 2023 $2.85 $3.41 $2.76 $3.35 7 694 440
Oct 30, 2023 $3.02 $3.28 $2.84 $3.01 24 310 572
Oct 27, 2023 $2.81 $3.39 $2.56 $2.64 8 803 574
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT